SPT Labtech and Biortus Launch Joint Laboratory of Structural Biology in China

Cambridge, UK and Wuxi, China - 26 March, 2025, SPT Labtech, a renowned multinational innovator specializing in automated instrumentation and consumables, joined forces with Biortus Biosciences Co., Ltd., a global leader in integrated capabilities spanning from gene to structural analysis, to inaugurate their strategic partnership and unveil the "Joint Laboratory of Structural Biology" at I-Campus.

This collaboration marks a profound alignment in structural biology research. As a trailblazer in high-end structural biology, Biortus leverages cutting-edge platforms including AI-driven protein design and production, in vitro assays and screening and advanced crystallography/cryo-EM technologies. Equipped with facilities such as X-ray diffractometers and 300 kV cryo-electron microscopes, the company boasts world-class expertise in drug-target protein preparation and structural analysis, supported by a team of seasoned industry leaders. By integrating Biortus’ structural biology prowess with SPT Labtech’s innovative sample preparation solutions, including chameleon, the joint laboratory aims to revolutionize Structure-Based Drug Discovery (SBDD), accelerating the development of next-generation therapeutics.

Signing Ceremony of the Structural Biology Joint Laboratory

At the ceremony, Biortus General Manager Jiaquan Wu (centre right) and SPT Labtech Chief Commercial Officer Morten Frost (centre left) formalized the historic partnership, symbolizing a shared commitment to scientific excellence.

Inauguration of the Structural Biology Joint Laboratory

The event heralds a new chapter of collaborative innovation, uniting both parties in a mission to redefine structural biology research. Together, they pledge to drive transformative breakthroughs, empowering the global pharmaceutical industry with pioneering solutions for drug discovery.

About Biortus

Biortus is a world-leading independent CRO with a mature lead generation platform including modular services in AI-driven soluble and membrane protein production, assay and screening, and structure determination in MicroED, Cryo-EM, and X-ray crystallography. Biortus now offers an off-the-shelf protein catalog to accelerate drug discovery.

Since 2009, Biortus has partnered with numerous research institutions, biotechnology companies, and pharmaceutical companies in all fields of research around the world with sites in China and Boston, USA. To learn more about our services and capabilities, visit http://en.biortus.bio/, or follow on LinkedIn.